Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;3(4):247-255.
doi: 10.1093/rb/rbw027. Epub 2016 Jul 13.

Multifunctional mussel-inspired copolymerized epigallocatechin gallate (EGCG)/arginine coating: the potential as an ad-layer for vascular materials

Affiliations

Multifunctional mussel-inspired copolymerized epigallocatechin gallate (EGCG)/arginine coating: the potential as an ad-layer for vascular materials

Rifang Luo et al. Regen Biomater. 2016 Dec.

Abstract

Surface properties are considered to be important factors in addressing proper functionalities. In this paper, a multifunctional mussel-inspired coating was prepared via the direct copolymerization of epigallocatechin gallate (EGCG) and arginine. The coating formation was confirmed by X-ray photoelectron spectroscopy and Fourier transform infrared spectra. The EGCG/arginine coating contained diverse functional groups like amines, phenols and carboxyls, whose densities were also tunable. Such mussel-inspired coating could also be applied as an ad-layer for its secondary reactivity, demonstrated by quartz crystal microbalance technique. Moreover, the tunable surface density of phenols showed potential ability in modulating endothelial cell and smooth muscle cell viability. The coatings rich in phenols presented excellent free radical scavenging property. Current results strongly indicated the potential of EGCG/arginine coatings to be applied as an ad-layer for vascular materials.

Keywords: Mussel chemistry; epigallocatechin gallate (EGCG); multifunction; surface modification; vascular devices.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) ATR-FTIR results of arginine, EGCG and EGCG/R-2/2 coating and (B) the comparison of different EGCG/arginine coatings
Figure 2.
Figure 2.
(A) XPS wide scan of different sample surfaces and (B) high-resolution survey of EGCG/R-4/2 coatings on C1s, N1s and O1s
Figure 3.
Figure 3.
(A) WCA results and (B) quantitative determination of diverse functional groups. Data expressed as mean ± SD (*P < 0.05)
Figure 4.
Figure 4.
(A) Morphology of platelet adhesion and activation on different surfaces and (B) QCM monitoring of bivalirudin (BVLD) immobilization onto EGCG/R-4/2 coating surface
Figure 5.
Figure 5.
(A) Cell counting results of adhered endothelial cells and (B) cytoskeletal actin stains of adhered endothelial cells cultured for 2 h. Data expressed as mean ± SD (***P < 0.001)
Figure 6.
Figure 6.
Endothelial cell staining results after the proliferation for 1 and 3 day cultured on different samples
Figure 7.
Figure 7.
(A) The free radical scavenging ability of different samples and (B) the protective effect of ECs against H2O2 injury with EGCG/R-4/2 and 316 L SS samples
Figure 8.
Figure 8.
Smooth muscle cells staining on different surfaces after culturing for 1, 3 and 5 days
Figure 9.
Figure 9.
Apoptosis of SMCs cultured on 316 L SS EGCG/R-4/2 coating surface after 1 and 3 days culture
Scheme 1.
Scheme 1.
The brief work of this paper on the preparation of EGCG/arginine coating and the investigation of the multifunction.

Similar articles

References

    1. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109:27–32. - PubMed
    1. Dangas GD, Claessen BE, Caixeta A, et al. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 2010;56:1897–907. - PubMed
    1. Kleiner LW, Wright JC, Wang Y. Evolution of implantable and insertable drug delivery systems. J Control Release 2014;181:1–10. - PubMed
    1. Wang Y, Zhang X. Vascular restoration therapy and bioresorbable vascular scaffold. Regen Biomater 2014;1:49–55. - PMC - PubMed
    1. Papafaklis MI, Chatzizisis YS, Naka KK, et al. Drug-eluting stent restenosis: effect of drug type, release kinetics, hemodynamics and coating strategy. Pharmacol Ther 2012;134:43–53. - PubMed

LinkOut - more resources